3 results
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... pharmacologic therapy ... benefits and risks of medications ... #Osteoporosis #AACE ... #2016 #Postmenopausal
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... exacerbations Drug Class ... : - Triple Therapy ... Dosing: 250 mcg tablet ... already on triple therapy
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
ASA class If ... event, follow ACC algorithm ... the type of and indication ... PCI/DES ( Levine 2016 ... stroke ( Doherty 2017